Skip to main content
Top
Published in: Endocrine 3/2002

01-04-2002

Injection of antiangiogenic agents into the macaque preovulatory follicle

Disruption of corpus luteum development and function

Authors: Timothy M. Hazzard, Richard M. Rohan, Theodore A. Molskness, John W. Fanton, Robert J. D’Amato, Dr. Richard L. Stouffer

Published in: Endocrine | Issue 3/2002

Login to get access
Metadata
Title
Injection of antiangiogenic agents into the macaque preovulatory follicle
Disruption of corpus luteum development and function
Authors
Timothy M. Hazzard
Richard M. Rohan
Theodore A. Molskness
John W. Fanton
Robert J. D’Amato
Dr. Richard L. Stouffer
Publication date
01-04-2002
Publisher
Humana Press
Published in
Endocrine / Issue 3/2002
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1385/ENDO:17:3:199

Other articles of this Issue 3/2002

Endocrine 3/2002 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine